TYMLOS® U.S. net sales continued to increase, reaching $34.4 million in the fourth quarter of 2018 and totaling $99.2 million for full-year 2018, exceeding the Company's guidance of $95-98 million.
TYMLOS® U.S. net sales continued to increase in the third quarter of 2018, totaling $27.6 million. 2019 Medicare Part D coverage for TYMLOS increased from 44% to 64% Elacestrant Phase 3 study to ...
Welcome, and thank you all for joining us on the conference call and webcast for Radius Fourth Quarter 2018 Financial Results and Business Update. Before we begin, I would like to remind you that ...
Shares of Radius Health, Inc.RDUS rallied almost 6% after the company announced its preliminary results for the full year 2018. However, shares of Radius declined 49.8% in the past year compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results